Cancer Immunology and Immunotherapy (eBook, PDF)

Redaktion: Dranoff, Glenn

• Format: PDF

Produktbeschreibung

The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that usher in a new era of cancer immunotherapy. These "first-in-class" treatments reflect the substantive progress that basic and translational scientists have made towards understanding the mechanisms underlying protective tumor immunity in cancer patients Immunotherapies were first explored at the turn of the twentieth century, but the crafting of potent treatments required more detailed knowledge of how the immune system responds to cancer. Advances in genetic, cellular, and biochemical technologies have begun to yield this critical information, focusing attention on immune recognition, regulation, and escape. Indeed, the dynamic interplay of these processes in the tumor microenvironment is now recognized to play a decisive role in determining disease outcome. This volume highlights the rapid progress and breadth of research in cancer immunology, and provides a framework for anticipating many more clinical successes in cancer immunotherapy.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Springer Berlin Heidelberg
• Seitenzahl: 306
• Erscheinungstermin: 11. April 2011
• Englisch
• ISBN-13: 9783642141362
• Artikelnr.: 37371545

Inhaltsangabe

Immune infiltration in human cancer: prognostic significance and disease control.
Subversion and coercion
The art of redirecting tumor immune surveillance.
STAT3: A target to enhance antitumor immune response.
Biology and clinical observations of regulatory T cells in cancer immunology.
Dendritic cell subsets as vectors and targets for improved cancer therapy.
Identification of human idiotype
specific T cells in lymphoma and myeloma.
Modulation of CTLA
4 and GITR for cancer immunotherapy.
Immunologically active biomaterials for cancer therapy.
Subject index

Rezensionen

From the reviews:
"This book comprises 13 reviews, contributed by members of a cross-section of groups working in the ... field of cancer immunology. ... this book is at its best when considering small and apparently discrete topics - its strength comes from being able to read all of these ideas on one place. ... Overall, this book gives a thorough and detailed overview of the current state of basic and translational research into cancer immunology ... . It's probably most appropriate for researchers ... ." (Victoria Lawson, Immunology News, November, 2011)